Upgrade to SI Premium - Free Trial

Volitionrx Limited (VNRX)

0.88 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/19/26)

Latest Headlines

Form 8-K VOLITIONRX LTD For: Jul 17 July 21, 2026 4:16 PM - SEC Filing Form EFFECT VOLITIONRX LTD July 20, 2026 6:03 AM - SEC Filing Form S-3 VOLITIONRX LTD July 10, 2026 5:28 PM - SEC Filing VolitionRx releases lung cancer study data for Nu.Q test July 7, 2026 8:17 AM - StreetInsider VolitionRx Announces Data Showing the Prognostic Value of its Nu.Q® Cancer Test July 7, 2026 8:17 AM - PR NewsWire Form 8-K VOLITIONRX LTD For: Jun 17 June 18, 2026 5:01 PM - SEC Filing Maxim Group Resumes VolitionRX (VNRX) at Buy June 18, 2026 7:55 AM - StreetInsider VolitionRx and Sysmex partner to optimize NETs diagnostic assay June 17, 2026 8:16 AM - StreetInsider VolitionRx Announces Collaboration with Sysmex June 17, 2026 8:15 AM - PR NewsWire Form 8-K VOLITIONRX LTD For: Jun 07 June 10, 2026 6:02 AM - SEC Filing Form 424B5 VOLITIONRX LTD June 9, 2026 9:26 AM - SEC Filing VolitionRx prices $4.6 million stock offering at $1.55 per share June 7, 2026 6:30 PM - StreetInsider VolitionRx Announces Pricing of $4.6 Million Public Offering June 7, 2026 6:30 PM - PR NewsWire Form 424B5 VOLITIONRX LTD June 5, 2026 4:02 PM - SEC Filing VolitionRx files patent for Ebola test using Nu.Q technology June 3, 2026 8:13 AM - StreetInsider VolitionRx Files New Patent Protecting its Nu.Q® NETs Test for Ebola Triage and Treatment Monitoring June 3, 2026 8:12 AM - PR NewsWire Form DEF 14A VOLITIONRX LTD For: Jul 17 June 2, 2026 4:22 PM - SEC Filing Benchmark Reiterates Hold Rating on VolitionRX (VNRX) June 2, 2026 8:42 AM - StreetInsider VolitionRx reports 300% Q1 revenue growth, submits feline cancer test May 27, 2026 8:17 AM - StreetInsider VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets May 27, 2026 8:17 AM - PR NewsWire Form 8-K VOLITIONRX LTD For: May 21 May 22, 2026 5:00 PM - SEC Filing VolitionRX (VNRX) PT Raised to $24 at Jones Trading May 18, 2026 4:02 PM - StreetInsider Form 8-K VOLITIONRX LTD For: May 12 May 15, 2026 4:46 PM - SEC Filing Form SCHEDULE 13G/A VOLITIONRX LTD Filed by: Lagoda Investment Management, L.P. May 15, 2026 4:08 PM - SEC Filing Volitionrx Limited (VNRX) Misses Q1 EPS by 93c May 15, 2026 9:31 AM - StreetInsider Form 10-Q VOLITIONRX LTD For: Mar 31 May 14, 2026 4:22 PM - SEC Filing Form 8-K VOLITIONRX LTD For: May 14 May 14, 2026 4:19 PM - SEC Filing VolitionRx Limited Announces First Quarter 2026 Financial Results and Business Update May 14, 2026 4:10 PM - PR NewsWire Form PRE 14A VOLITIONRX LTD For: May 12 May 13, 2026 4:15 PM - SEC Filing VolitionRx Limited Schedules First Quarter 2026 Earnings Conference Call and Business Update May 11, 2026 8:19 AM - PR NewsWire VolitionRx Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats May 6, 2026 8:17 AM - PR NewsWire Form 10-K/A VOLITIONRX LTD For: Dec 31 April 30, 2026 4:46 PM - SEC Filing Volition Announces Breakthrough Finger-Prick Detection of Nucleosomes; Expanding Global Market Potential for Sepsis Testing April 29, 2026 8:17 AM - PR NewsWire Full Article List